4DMedical Limited (ASX:4DX)
1.900
+0.060 (3.26%)
At close: Dec 5, 2025
4DMedical Revenue
In the fiscal year ending June 30, 2025, 4DMedical had annual revenue of 5.85M AUD with 55.91% growth. 4DMedical had revenue of 2.96M in the half year ending June 30, 2025, with 1,171.16% growth.
Revenue
5.85M
Revenue Growth
+55.91%
P/S Ratio
167.51
Revenue / Employee
47.20K
Employees
124
Market Cap
980.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.85M | 2.10M | 55.91% |
| Jun 30, 2024 | 3.75M | 3.04M | 422.45% |
| Jun 30, 2023 | 718.58K | -335.72K | -31.84% |
| Jun 30, 2022 | 1.05M | 837.32K | 385.90% |
| Jun 30, 2021 | 216.98K | -1.02M | -82.40% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |